EPIGENETICS IN SCLC TO EARLY DETECT TREATMENT RESISTANCE AND DISCOVERY NEW DRUGGABLE PATHWAYS
Ente Finanziatore: Bando per la Ricerca Istituzionale
Principal Investigator: Dott.ssa Beninato Teresa
Data di inizio:
Data di fine:
Struttura Principale: EPIGENETICS IN SCLC TO EARLY DETECT TREATMENT RESISTANCE AND DISCOVERY NEW DRUGGABLE PATHWAYS
Study on the influence of epigenetic modifications on tumor immunogenicity and response to first-line chemo-immunotherapy treatment in patients with small cell lung cancer.
Principal Investigator Dr. Beninato Teresa
Dr, PhD De Cecco Loris
Dr. Prelaj Arsela
Integrated Biology of Rare Tumors
Research Area, Departmental Simple Structure
Last update: 26/05/2025